Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 5Withdrawn 1Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Prostatic Neoplasms 1Liver Neoplasms 1Kidney Neoplasms 1Central Nervous System Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Hepatocellular 1

Interventions

Radiotherapy 19Temozolomide 11Cisplatin 9Vincristine 8Chemotherapy, Adjuvant 8Carboplatin 8Etoposide 6Lomustine 5Methotrexate 4Thiotepa 3Peripheral Blood Stem Cell Transplantation 3Magnetic Resonance Spectroscopy 3Ifosfamide 3Filgrastim 3Cyclophosphamide 3Carmustine 3pegfilgrastim 2Tamoxifen 2Surgical Procedures, Operative 2Psychiatric Rehabilitation 2Pemetrexed 2Mental Status and Dementia Tests 2Hyperbaric Oxygenation 2Ethanol 2Erlotinib Hydrochloride 2Dexamethasone 2Amplified Fragment Length Polymorphism Analysis 2nedaplatin 1motexafin gadolinium 1lonafarnib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Central Nervous System Neoplasms × motexafin gadolinium × Clear all
NCT00514397 2013-08-12

Temozolomide and Radiation Therapy in Treating Young Patients With Pontine Glioma

National Cancer Institute (NCI)

Phase 2 Unknown
43 enrolled
CNS

Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡